Corporate

Oct, 2017

News / Corporate

Oct 31, 2017

Astellas Reports First Half FY2017 Financial Results, Revises Fiscal Year Outlook

Tokyo, October 31, 2017 - Astellas Pharma Inc. (TSE: 4503, President and CEO: Yoshihiko Hatanaka, “Astellas”) today announced the financial results for the first six months of fiscal year...

News / Corporate

Oct 24, 2017

Astellas Oncology Selects Five C3 Prize® Finalists to Pitch Ideas for Changing Cancer Care at the Union for International Cancer Control (UICC) World Cancer Leaders' Summit

Astellas today announced the five C3 Prize finalists chosen from more than 160 entries to present their ideas to change cancer care in a live forum at the Union for International Cancer Control...

News / Corporate

Oct 19, 2017

Astellas and Universal Cells, Inc. Announce a Collaboration Utilizing Universal Donor Cell Technology

Astellas Pharma Inc. (TSE: 4503, President and CEO: Yoshihiko Hatanaka, "Astellas") and Universal Cells, Inc. (CEO: Claudia Mitchell, "Universal Cells") today announced that Astellas Institute for...

Sep, 2017

News / Corporate

Sep 06, 2017

Astellas Announces Launch of 'Keep on Dancing' Sweepstakes

Astellas Pharma US, Inc. announced today the launch of the 'Keep on Dancing' Sweepstakes, sponsored by Myrbetriq® (mirabegron). Fans age 18 and older can enter for a chance to win a trip for two...

Aug, 2017

News / Corporate

Aug 02, 2017

Astellas Announces Leadership Changes in Corporate Affairs Organization

NORTHBROOK, Ill., August 2, 2017 – Astellas today announced three senior-level changes in its Corporate Affairs organization, and several promotions throughout the function. Moyra Knight is...